- Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23
- Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23
- Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
- Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
- Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
- Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
- Coloplast A/S - Allokering af aktieoptioner
- Coloplast A/S - Allocation of Share Options
- Coloplast launches male catheter designed to reduce the risk of urinary tract infections
- Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
More ▼
Key statistics
On Friday, Coloplast A/S (CBHDX:GER) closed at 115.35, 17.70% above the 52 week low of 98.00 set on Jun 17, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 115.25 |
---|---|
High | 115.35 |
Low | 115.25 |
Bid | 114.90 |
Offer | 116.20 |
Previous close | 115.45 |
Average volume | 129.92 |
---|---|
Shares outstanding | 198.00m |
Free float | 108.81m |
P/E (TTM) | 38.11 |
Market cap | 170.36bn DKK |
EPS (TTM) | 22.58 DKK |
Annual div (ADY) | 2.69 EUR |
---|---|
Annual div yield (ADY) | 2.33% |
Div ex-date | May 15 2023 |
Div pay-date | May 17 2023 |
Data delayed at least 15 minutes, as of Jun 09 2023 16:35 BST.
More ▼